Page last updated: 2024-10-22

adrenic acid and Disease Models, Animal

adrenic acid has been researched along with Disease Models, Animal in 2 studies

adrenic acid: RN given refers to cpd without isomeric designation

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"The CDAHFD-fed db/db mice with hepatic steatosis, inflammation, mild fibrosis, obesity, and hypercholesterolemia displayed significantly higher hepatic and plasma levels of free adrenic acid (p < 0."7.85Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. ( Azuma, T; Horas H Nababan, S; Kawano, Y; Kobayashi, T; Nishiumi, S; Yoshida, M, 2017)
"The CDAHFD-fed db/db mice with hepatic steatosis, inflammation, mild fibrosis, obesity, and hypercholesterolemia displayed significantly higher hepatic and plasma levels of free adrenic acid (p < 0."3.85Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. ( Azuma, T; Horas H Nababan, S; Kawano, Y; Kobayashi, T; Nishiumi, S; Yoshida, M, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horas H Nababan, S1
Nishiumi, S1
Kawano, Y1
Kobayashi, T1
Yoshida, M1
Azuma, T1
Signorini, C1
Cardile, V1
Pannuzzo, G1
Graziano, ACE1
Durand, T1
Galano, JM1
Oger, C1
Leoncini, S1
Cortelazzo, A1
Lee, JC1
Hayek, J1
De Felice, C1

Other Studies

2 other studies available for adrenic acid and Disease Models, Animal

ArticleYear
Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease.
    Archives of biochemistry and biophysics, 2017, 06-01, Volume: 623-624

    Topics: Adult; Animals; Cytokines; Disease Models, Animal; Disease Progression; Fatty Acids, Unsaturated; Fe

2017
Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity.
    Free radical biology & medicine, 2019, 08-01, Volume: 139

    Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Galactosylceramida

2019